Marlena Fejzo

A Short Biography:

Dr. Marlena Fejzo is a faculty researcher with joint appointments in the department of Medicine at UCLA and the department of Obstetrics and Gynecology at USC. Her primary focus is in improving women’s health. She has published papers on her genetic studies of many diseases of women including ovarian cancer, breast cancer, and multiple sclerosis and she discovered the first gene involved in uterine fibroids. She is also a mother of three. In 1999 she lost a baby in the 2nd trimester due to Hyperemesis Gravidarum (HG). HG changed her life - her family and her career. HG is the 2nd leading indicator for hospitalization during pregnancy and yet very little research dollars are spent on it. Drug companies and universities virtually stopped supporting HG research or drug development after babies were born without their limbs when thalidomide was given to treat HG in the 1950s. Through her partnership with the HER Foundation www.helpher.org, she has begun to scratch the surface in answering important questions about HG including the psychosocial burden, therapeutic termination, treatment trends, a link between HG and ovarian hyperstimulation syndrome, familial aggregation, recurrence risk, post-traumatic stress, prolonged HG, extreme weight loss, change in partner and recurrence risk, increased risk of neurodevelopmental delay in children exposed to HG in utero, outcomes following exposure to ondansetron, and identification of a link between RYR2 and HG. Her goal is to unlock the biological mechanisms behind HG using a genetic approach. To date, the most significant risk factor associated with HG is having a sibling with HG, which constitutes a greater than 17-fold increased risk and suggests a strong genetic component to the disease. Ultimately, Dr. Fejzo's study will drive development of new and better therapies that target the cause of the disease, not just the symptoms, and limit the associated maternal and fetal suffering.


Work Titles

Contact Information:

Email Address:

mfejzo@mednet.ucla.edu


Work Phone Number:

(310) 206-1408

Mailing Address:

Laboratory
675 Charles E Young S
12206 Tweed Ln
Los Angeles, CA 90095


Work Address:

Laboratory
675 Charles E Young S
Los Angeles, CA 90095


Detailed Biography:

Peer Reviewed Publications:

  1. Fletcher JA, Kozakewich HP, Schoenberg ML, and Morton CC: Cytogenetic findings in pediatric adipose tumors: consistent rearrangement of chromosome 8 in lipoblastoma.  Genes, Chromosomes and Cancer 6:24-29 (1993).

 

  1. Mashal RD, Schoenberg Fejzo ML , Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, and Sklar J: Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in leiomyomata development. Genes, Chromosomes and Cancer 11:1-6 (1994).

 

  1. Hansen MJ, Chen LH, Schoenberg Fejzo ML , and Belasco JG: OmpA 5' untranslated region impedes the major pathway for mRNA degradation in E. Coli.  Molecular Microbiology 12(5): 707-16 (1994).

 

  1. Schoenberg Fejzo M , Yoon S-J, Montgomery KT, Rein MS, Weremowicz S, Krauter K, Dorman TE, Fletcher JA, Mao J, Moir DT, Kucherlapati RS, Morton CC:  Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma and lipoma. Physical mapping of the 12q14-15 breakpoint region in uterine leiomyomata.  Genomics 26:265-271 (1995).

 

  1. Schoenberg Fejzo M , Ashar H, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S,Morton CC, Chada K:  Disruption of the architectural factor HMGI-C:  DNA-binding A-T hook motifs fused in lipomas to distinct transcriptional regulatory domains.  Cell, 82: 57-65 (1995).

 

  1. Basson CT, MacRae CA, Schoenberg Fejzo M , Morton CC, Spinner NB, Genin A, Krug E, Seidman JG, Seidman C: Identification, characterization, and chromosomal localization of the human homolog (hES) of ES/130.  Genomics, 35: 628-631 (1996).

 

  1. Schoenberg Fejzo M , Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, Yoon S-J, Kucherlapati RS, Chada K, Morton CC: Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas.  Genes, Chromosomes and Cancer, 17: 1-6 (1996).

 

  1. Schoenberg Fejzo M , Godfrey T, Chen C, Waldman F, Gray J: Localization of amplification and translocations in breast cancer to a single genetic locus on chromosome 8.  Genes, Chromosomes and Cancer, 22: 105-113 (1998).

 

  1. Pallaoro M, Schoenberg Fejzo M , Shayesteh L, Blount JL, Caughey GH:  Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.  Journal of Biological Chemistry, 274(6): 3355-3362 (1999).

 

  1. Balleine R, Schoenberg Fejzo M , Sathasivam P, Basset P, Clarke CL, Gunning P, Byrne J:  The D52 (TPD52) gene is a candidate target gene for events resulting in increased chromosome 8q21 copy number in human breast carcinoma.  Genes, Chromosomes and Cancer, 29(1): 48-57 (2000).

 

  1. Schoenberg Fejzo M , Slamon DJ:  Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins.  American Journal of Pathology, 159(5):  1645-50 (2001).

 

  1. Schoenberg Fejzo M , Saarela J, Chen D, Finnila S, Parkkonen M, Kuokkanen S, Sobel E, Tienari PJ, Sumelahti ML, Wikstrom J, Elovaara I, Koivisto K, Pirttila T, Reunanen M, Palotie A, Peltonen L.: Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24. Hum Mol Genet. Sep 15;11(19):2257-67 (2002).

 

  1. Byrne JA, Balleine RL, Schoenberg Fejzo M , Mercieca J, Chiew Y-E, Livnat Y, Heaps LS, Peters G, Byth K Karlan K, Slamon DJ, Harnett P, deFazio A.:  Tumor Protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.  International Journal of Cancer. Dec 20;117(6):1049-54 (2005).

 

  1. Schoenberg Fejzo M , Wakefield MacGibbon K. [On the article "psychological approach of hyperemis gravidarum" (J Gynecol Obstet Reprod Biol 7-2004) and response from the author]J Gynecol Obstet Biol Reprod (Paris). Sep;34(5):507; author reply 507-8 (2005).

 

  1. Poursharif B, Korst L, MacGibbon KW, Schoenberg Fejzo M , Romero R, Goodwin TM.  Voluntary termination in a large cohort of women with hyperemesis gravidarum. Contraception. Dec;76(6):451-5(2007).

 

  1. Milstein M, Mooser CK, Patel1 A, Hu H, Schoenberg Fejzo M , Slamon DJ, Lee Goodglick L, 4, Dry S, Colicelli J.  RIN1 is a Breast Tumor Suppressor Gene.  Cancer Research. Dec 15;67(24):11510-6 (2007).

 

  1. Poursharif B, Schoenberg Fejzo M , MacGibbon KW, Korst LM, Romero R, Goodwin TM:  Psychosocial Burden of Hyperemesis Gravidarum. American Journal of Perinatology. Mar;28(3):176-81 (2008).

 

  1. Goodwin TM, Poursharif B, Korst LM, MacGibbon K, Schoenberg Fejzo M .  Secular trends in the treatment of hyperemesis gravidarum. Am J Perinatol. Mar;25(3):141-7 (2008).

 

  1. Konecny GE, Venkatesan N, Yang G, Dering J, Ginther C, Finn R, Rahmeh R, Schoenberg Fejzo M , Toft T, Jiang SW,  Slamon DJ,  Podratz KC. Activity of Lapatinib a Novel HER2 and EGFR Dual Kinase Inhibitor in Endometrial Cancer Cells. Br J Cancer. Mar 25;98(6):1076-1084 (2008).

 

  1. Schoenberg Fejzo M , Ginther C, Anderson L, Ramos L, Dering J, Walsch C, Karlan B, Slamon DJ. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.  Genes, Chromosomes, Cancer. Oct;47(10):873-83 (2008).

 

  1. Schoenberg Fejzo M, Ingles SA, Wang W, Wilson M, MacGibbon KW, Romero R, Goodwin TM. High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals.Eur J Obstet Gynecol Reprod Biol. Nov;141(1):13-7 (2008).

 

  1. Schoenberg Fejzo M, Poursharif B , Korst L, Munch S, MacGibbon K, Romero R, Goodwin TM. Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum.J Women’s Health, Dec;18(12):1981-7 (2009).

 

  1. Schoenberg Fejzo M , Romero R, Goodwin TM. Patients with history of hyperemesis gravidarum have similar symptoms during egg stimulation and develop ovarian hyperstimulation syndrome:  case series.  Fertility and Sterility,Oct Jan;93(1):267 (2010).

 

  1. Wainberg Z.A., Desai A., Safran B., Anghel A., Schoenberg Fejzo M. , Hecht J.R., Slamon D.J., Finn R.S. The EGFR and HER2 dual kinase inhibitor lapatinib selectively inhibits HER2 amplified gastric cancer cells. Clin Cancer Res, Mar 1;16(5):1509-19. (2010). 

 

  1. Schoenberg Fejzo M , Slamon DJ.  Tissue microarrays from frozen tissues-OCT technique.   Methods Mol Biol., 664:73-80 (2010).

 

  1. Zhu M, Schoenberg Fejzo M , Anderson L, Dering J, Ginther C, Ramos L, Gasson JC, Karlan BY, Slamon DJ. Periostin promotes ovarian cancer angiogenesis and metastasis. Gynecol Oncol. Nov;119(2):337-44 (2010).

 

  1. Zhang Y., Cantor R., MacGibbon K, Romero R, Goodwin TM, Mullin P, Schoenberg Fejzo M .  Familial Aggregation of Hyperemesis Gravidarum.  AJOG, Mar;204(3):230 (2011).

 

  1. Christodoulou J, Mullin PM, Romero R, Goodwin TM, MacGibbon K, Gold JI, Schoenberg Fejzo M., Posttraumatic Stress Symptoms (PTSS) following Hyperemesis Gravidarum (HG) J Matern Fetal Neonatal Med. Nov;24(11):1307-11 (2011).

 

  1. Schoenberg Fejzo M ., Ginther C., Dering J., Anderson L., Venkatessen N., Karlan B., Slamon DJ.  Knock-down of ovarian cancer amplification target ADRM1 leads to down regulation of GIPC1 and up-regulation of RECK.  Genes, Chromosomes, Cancer. Jun;50(6):434-41 (2011).

 

  1. Schoenberg Fejzo M , MacGibbon K, Romero R, Goodwin TM. Recurrence Risk of Hyperemesis Gravidarum.  J Midwifery and Women’s Health. Mar-Apr;56(2):132-6 (2011).

 

  1. Mullin P, Bray A, Schoenberg-Paik F, MacGibbon K, Romero R, Goodwin TM, Schoenberg Fejzo M.   Prenatal Exposure to Hyperemesis Gravidarum Linked to Increased Risk of Psychological and Behavioral Disorders in Adulthood.  J Dev Origins of Disease, 2:200-204 (2011).

 

  1. Mullin PM, Ching C, Schoenberg F, Romero R, Goodwin TM, MacGibbon K, Schoenberg Fejzo M., Risk Factors, Treatments, and Outcomes Associated with Prolonged Hyperemesis Gravidarum (HG) J Matern Fetal Neonatal Med. Jun;25(6):632-6 (2012).

 

  1. Schoenberg Fejzo MS, Ching C, Schoenberg FP, Macgibbon K, Romero R, Goodwin TM, Mullin PM. Change in paternity and recurrence of hyperemesis gravidarum .   J Matern Fetal Neonatal Med., 25(8):1241-5 (2012).

 

  1. Mullin P, Bray A, Vu V, Schoenberg-Paik F, MacGibbon K, Romero R, Goodwin TM, Schoenberg Fejzo M .  No increased Risk of Psychological/Behavioral Disorders in Siblings of Women with Hyperemesis Gravidarum unless their Mother had HG. J Dev Origins of Disease, 3(5):375-379 (2012).

 

  1. Schoenberg Fejzo M, Anderson L, von Euw EM, Kalous O, Avliyakulov NK, Haykinson MJ, Konecny GE, Finn RS, Slamon DJ.  Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer. Int J MolSci. Feb 1;14(2):3094-109 (2013).

 

  1. Ather F, Hamidi H, Schoenberg Fejzo M , Letrent S, Finn RS, Kabbinavar F, Head C, Wong SG. Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab. PLoS One,8(2)(2013).

 

  1. Schoenberg Fejzo M , Magtira A, Schoenberg FP, Macgibbon K, Mullin P, Romero R, Tabsh K.Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum.   Eur J Obstet Gynecol Reprod Biol. Jun 7(2013).

 

  1. Karlan BY, Dering J, Walsh C, Orsulic S, Lester J, Anderson L, Ginther C, Schoenberg Fejzo M , Slamon D.  POSTN -Associated Stromal Signature Predicts Poor Prognosis in Serous Ovarian Cancer. Gynecol Oncol. Feb;132(2):334-42 (2014).

 

  1. Hamidi H, Lu M, Chau K, Anderson L, Schoenberg Fejzo M , Ginther C, Linnartz R, Zubel A; Slamon DJ; Finn R.  KRAS mutational subtypes and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition.  British Journal of Cancer, (2014). 

 

  1. Magtira A, Schoenberg FP, Macgibbon K, Tabsh K, Schoenberg Fejzo M . Psychiatric factors do not affect recurrence risk of Hyperemesis Gravidarum. JOGR, 41(4):512-16 (2015).

 

  1. Schoenberg Fejzo M , Magtira A, Schoenberg FP, Macgibbon K, Mullin P. Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol.;189:79-84 (2015).

 

  1. Schoenberg Fejzo M, Anderson L, Chen H-W, Anghel A, Zhuo J, Anchoori R, Roden R, Slamon DJ.  ADRM1 amplified metastasis gene in gastric cancer.  Genes, Chromosomes,Cancer. (2015). 

 

  1. Schoenberg Fejzo M , Macgibbon K, Mullin P.  Frequency of intestinal obstruction in pregnancies exposed to ondansetron. Reproductive Toxicology, Nov;57:207(2015).

 

  1. Macgibbon K, Schoenberg Fejzo M , Mullin P.  Mortality secondary to Hyperemesis Gravidarum: a case report.   Women’s Health and Gynecology, (2015). 

 

  1. Schoenberg Fejzo M , Schoenberg FP, Macgibbon K, Magtira A, Martin B, Mullin P. Long-term health effects in children exposed in-utero to hyperemesis gravidarum. Clinical Obstetric, Gynecology and Reproduction.  2(2): 150-154 (2016).

 

  1. Schoenberg Fejzo M , Macgibbon K, Mullin P. Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.Reprod Toxicol.Jul;62:87-91(2016).

 

  1. Schoenberg Fejzo M , MacGibbon K, Mullin PM.  Why are women still dying from nausea and vomiting of pregnancy? Gynecology and Obstetrics Case Report. Insight Medical Publishing Journals (2016). 

 

  1. Tian R, MacGibbon K, Martin B, Mullin P, Schoenberg Fejzo M ,.  Analysis of pre- and post-pregnancy issues in women with hyperemesis gravidarum.  Autonomic Neuroscience, Basic and Clinical, 202:73-78.(2017).

 

  1. Schoenberg Fejzo M, Myhre R, Colodro-Conde L, MacGibbon K, Sinsheimer J, Reddy PL, Pajukanta P, Nyholt D, Wright M, Martin NG, Engel SM, Medland SE, Magnus P, Mullin PM. Genetic analysis of Hyperemesis Gravidarum reveals association with intracellular calcium release channel (RYR2).  Molecular and Cellular Endocrinology, Mol Cell Endocrinol. 439:308-316. (2017). 

 

  1. Schoenberg Fejzo M , Anderson L, Chen H-W, Gandique E, Kalous O, Conklin D, Slamon DJ.  Proteasome Ubiquitin Receptor PSMD4 is an Amplification Target in Breast Cancer and May Predict Sensitivity to PARPi. Genes, Chromosomes, Cancer 56(8):589-597(2017).

 

  1. Schoenberg Fejzo M , Measures of depression and anxiety in women with hyperemesis gravidarum are flawed. Invited Commentary on the article entitled "Mitchell-Jones N, Gallos I, Farren J, et al. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis. BJOG. 2017 Jan;124(1):20-30. Evidence-based Nursing (2017).

Publications:

Fejzo Marlena S, Macgibbon Kimber   Hyperemesis gravidarum: it is time to put an end to the misguided theory of a psychiatric etiology General hospital psychiatry, ; 34(6): 699-700; author reply 700-1.
Fejzo Marlena S, Anderson Lee, Chen Hsiao-Wang, Guandique Enrique, Kalous Ondrej, Conklin Dylan, Slamon Dennis J   Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi Genes, chromosomes & cancer, 2017; 56(8): 589-597.
Fejzo Marlena Schoenberg   Measures of depression and anxiety in women with hyperemesis gravidarum are flawed Evidence-based nursing, 2017; 20(3): 78-79.
Tian Rayna, MacGibbon Kimber, Martin Bhuvan, Mullin Patrick, Fejzo Marlena   Analysis of pre- and post-pregnancy issues in women with hyperemesis gravidarum Autonomic neuroscience : basic & clinical, 2017; 202(3): 73-78.
Fejzo Marlena Schoenberg, Myhre Ronny, Colodro-Conde Lucía, MacGibbon Kimber W, Sinsheimer Janet S, Reddy M V Prasad Linga, Pajukanta Päivi, Nyholt Dale R, Wright Margaret J, Martin Nicholas G, Engel Stephanie M, Medland Sarah E, Magnus Per, Mullin Patrick M   Genetic analysis of hyperemesis gravidarum reveals association with intracellular calcium release channel (RYR2) Molecular and cellular endocrinology, 2017; 439(3): 308-316.
Fejzo Marlena, MacGibbon Kimber, Mullin Patrick   Response to the questions submitted by Mr. Reichmann Reproductive toxicology (Elmsford, N.Y.), 2016; 66(3): 123.
Fejzo Marlena S, MacGibbon Kimber W, Mullin Patrick M   Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Reproductive toxicology (Elmsford, N.Y.), 2016; 62(3): 87-91.
Fejzo Marlena S, MacGibbon Kimber, Mullin Patrick   Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum Reproductive toxicology (Elmsford, N.Y.), 2015; 57(3): 207.
Fejzo Marlena S, Anderson Lee, Chen Hsiao-Wang, Anghel Adrian, Zhuo Jiaying, Anchoori Ravi, Roden Richard, Slamon Dennis J   ADRM1-amplified metastasis gene in gastric cancer Genes, chromosomes & cancer, 2015; 57(3): 207.
Fejzo Marlena S, Magtira Aromalyn, Schoenberg Frederic Paik, Macgibbon Kimber, Mullin Patrick M   Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum European journal of obstetrics, gynecology, and reproductive biology, 2015; 189(3): 79-84.
Magtira Aromalyn, Schoenberg Frederic Paik, MacGibbon Kimber, Tabsh Khalil, Fejzo Marlena S   Psychiatric factors do not affect recurrence risk of hyperemesis gravidarum The journal of obstetrics and gynaecology research, 2015; 41(4): 512-6.
Karlan Beth Y, Dering Judy, Walsh Christine, Orsulic Sandra, Lester Jenny, Anderson Lee A, Ginther Charles L, Fejzo Marlena, Slamon Dennis   POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer Gynecologic oncology, 2014; 132(2): 334-42.
Fejzo Marlena S, Magtira Aromalyn, Schoenberg Frederic Paik, MacGibbon Kimber, Mullin Patrick, Romero Roberto, Tabsh Khalil   Antihistamines and other prognostic factors for adverse outcome in hyperemesis gravidarum European journal of obstetrics, gynecology, and reproductive biology, 2013; 170(1): 71-6.
Fejzo Marlena S, Anderson Lee, von Euw Erika M, Kalous Ondrej, Avliyakulov Nuraly K, Haykinson Michael J, Konecny Gottfried E, Finn Richard S, Slamon Dennis J   Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer International journal of molecular sciences, 2013; 14(2): 3094-109.
Ather Ferdows, Hamidi Habib, Fejzo Marlena S, Letrent Stephen, Finn Richard S, Kabbinavar Fairooz, Head Christian, Wong Steven G   Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab PloS one, 2013; 8(2): e56112.
Fejzo Marlena S, Ching Chunyu, Schoenberg Frederic P, Macgibbon Kimber, Romero Roberto, Goodwin T Murphy, Mullin Patrick M   Change in paternity and recurrence of hyperemesis gravidarum The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2012; 25(8): 1241-5.
Mullin Patrick M, Ching ChunYu, Schoenberg Frederic, MacGibbon Kimber, Romero Roberto, Goodwin T Murphy, Fejzo Marlena S   Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2012; 25(6): 632-6.
Christodoulou-Smith Joan, Gold Jeffrey I, Romero Roberto, Goodwin Thomas M, Macgibbon Kimber W, Mullin Patrick M, Fejzo Marlena S   Posttraumatic stress symptoms following pregnancy complicated by hyperemesis gravidarum The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011; 24(11): 1307-11.
Fejzo Marlena S, Ginther Chuck, Dering Judy, Anderson Lee, Venkatesan Natarajan, Konecny Gottfried, Karlan Beth, Slamon Dennis J   Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK Genes, chromosomes & cancer, 2011; 50(6): 434-41.
Zhang Yafeng, Cantor Rita M, MacGibbon Kimber, Romero Roberto, Goodwin Thomas M, Mullin Patrick M, Fejzo Marlena S   Familial aggregation of hyperemesis gravidarum American journal of obstetrics and gynecology, 2011; 204(3): 230.e1-7.
Fejzo Marlena S, Macgibbon Kimber W, Romero Roberto, Goodwin T Murphy, Mullin Patrick M   Recurrence risk of hyperemesis gravidarum Journal of midwifery & women's health, 2011; 56(2): 132-6.
Zhu Min, Fejzo Marlena S, Anderson Lee, Dering Judy, Ginther Charles, Ramos Lillian, Gasson Judith C, Karlan Beth Y, Slamon Dennis J   Periostin promotes ovarian cancer angiogenesis and metastasis Gynecologic oncology, 2010; 119(2): 337-44.
Fejzo Marlena Schoenberg, Slamon Dennis J   Tissue microarrays from frozen tissues-OCT technique Methods in molecular biology (Clifton, N.J.), 2010; 664: 73-80.
Wainberg Zev A, Anghel Adrian, Desai Amrita J, Ayala Raul, Luo Tong, Safran Brent, Fejzo Marlena S, Hecht J Randolph, Slamon Dennis J, Finn Richard S   Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo Clinical cancer research : an official journal of the American Association for Cancer Research, 2010; 16(5): 1509-19.
Fejzo Marlena S, Romero Roberto, Goodwin T Murphy   Patients with a history of hyperemesis gravidarum have similar symptoms during egg stimulation and develop ovarian hyperstimulation syndrome: case series Fertility and sterility, 2010; 93(1): 267.e9-11.
Fejzo Marlena S, Poursharif Borzouyeh, Korst Lisa M, Munch Shari, MacGibbon Kimber W, Romero Roberto, Goodwin T Murphy   Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum Journal of women's health (2002), 2009; 18(12): 1981-7.
Fejzo Marlena S, Ingles Sue Ann, Wilson Melissa, Wang Wei, MacGibbon Kimber, Romero Roberto, Goodwin Thomas M   High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals European journal of obstetrics, gynecology, and reproductive biology, 2008; 141(1): 13-7.
Fejzo Marlena S, Dering Judy, Ginther Chuck, Anderson Lee, Ramos Lilian, Walsh Christine, Karlan Beth, Slamon Dennis J   Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target Genes, chromosomes & cancer, 2008; 47(10): 873-83.
Goodwin T Murphy, Poursharif Borzouyeh, Korst Lisa M, MacGibbon Kimber W, Romero Roberto, Fejzo Marlena S   Secular trends in the treatment of hyperemesis gravidarum American journal of perinatology, 2008; 25(3): 141-7.
Poursharif Borzouyeh, Korst Lisa M, Macgibbon Kimber W, Fejzo Marlena S, Romero Roberto, Goodwin T Murphy   Elective pregnancy termination in a large cohort of women with hyperemesis gravidarum Contraception, 2007; 76(6): 451-5.
Milstein Marc, Mooser Chelsea K, Hu Hailiang, Fejzo Marlena, Slamon Dennis, Goodglick Lee, Dry Sarah, Colicelli John   RIN1 is a breast tumor suppressor gene Cancer research, 2007; 67(24): 11510-6.
Byrne Jennifer A, Balleine Rosemary L, Schoenberg Fejzo Marlena, Mercieca Janelle, Chiew Yoke-Eng, Livnat Yael, St Heaps Luke, Peters Gregory B, Byth Karen, Karlan Beth Y, Slamon Dennis J, Harnett Paul, Defazio Anna   Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer International journal of cancer. Journal international du cancer, 2005; 117(6): 1049-54.
Saarela Janna, Schoenberg Fejzo Marlena, Chen Daniel, Finnilä Saara, Parkkonen Maikki, Kuokkanen Satu, Sobel Eric, Tienari Pentti J, Sumelahti Marja-Liisa, Wikström Juhani, Elovaara Irina, Koivisto Keijo, Pirttilä Tuula, Reunanen Mauri, Palotie Aarno, Peltonen Leena   Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24 Human molecular genetics, 2002; 11(19): 2257-67.

Does this profile need updating? Contact Us